These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4995765)

  • 41. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs.
    Cazenave JP; Benveniste J; Mustard JF
    Lab Invest; 1979 Sep; 41(3):275-85. PubMed ID: 112332
    [No Abstract]   [Full Text] [Related]  

  • 44. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
    Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
    Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between viruses and platelets: requirement of haemolytic activity for platelet aggregation induced by paramyxoviruses.
    Chernesky MA; Larke RP; Turpie AG
    J Gen Virol; 1973 Nov; 21(2):205-13. PubMed ID: 4357746
    [No Abstract]   [Full Text] [Related]  

  • 46. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 .
    Boullin DJ; Green AR; Price KS
    J Physiol; 1972 Mar; 221(2):415-26. PubMed ID: 5020984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor XII and blood platelets after whole-body irradiation.
    Klír P; Pospísil J; Skala E; Dienstbier Z; Tachecí O
    Strahlentherapie; 1973 Dec; 146(6):713-7. PubMed ID: 4792266
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1974 Nov; 77(2):135-49. PubMed ID: 4374890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet aggregation testing.
    Gensini G; Fortini A; Laureano R
    Ric Clin Lab; 1981; 11 Suppl 1():151-61. PubMed ID: 6821315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets.
    Peerschke EI
    Thromb Haemost; 1995 May; 73(5):862-7. PubMed ID: 7482417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of aggregation of human blood platelets by ultraviolet light: action spectrum and structural changes.
    Doery JC; Dickson RC; Hirsh J
    Blood; 1973 Oct; 42(4):551-5. PubMed ID: 4778704
    [No Abstract]   [Full Text] [Related]  

  • 55. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.
    Feinstein MB; Fraser C
    J Gen Physiol; 1975 Nov; 66(5):561-81. PubMed ID: 172596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactions of polylysine with human platelets in plasma and in suspensions of washed platelets.
    Guccione MA; Packham MA; Kinlough-Rathbone RL; Perry DW; Mustard JF
    Thromb Haemost; 1976 Nov; 36(2):360-75. PubMed ID: 827032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of neutral proteases from blood leukocytes on human platelets.
    Bykowska K; Kaczanowska J; Karpowicz M; Stachurska J; Kopeć M
    Thromb Haemost; 1983 Dec; 50(4):768-72. PubMed ID: 6320486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggregation and release reaction induced in human blood platelets by zymosan.
    Zucker MB; Grant RA
    J Immunol; 1974 Mar; 112(3):1219-30. PubMed ID: 4811967
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of platelet antagonists on the reduction in platelet density caused by microbubbles in vitro.
    Thorsen T; Ovstedal T; Vereide A; Holmsen H
    Undersea Biomed Res; 1986 Sep; 13(3):289-303. PubMed ID: 3022436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.